Hydrochloric Acid

Hydrochloric Acid

SCHEMBL715359

CCC[N+]1(C)CCCC1.[Cl-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.32
CHRM1 known ✓ P11229 1/20 0.32
CHRM3 known ✓ P20309 1/20 0.32
BBOX1 O75936 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.34
CHRNA7 P36544 3/20 0.34
LMNA P02545 4/20 0.34
KMT2A Q03164 2/20 0.34
APOBEC3A P31941 2/20 0.34
APOBEC3G Q9HC16 2/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
CHRNB2 P17787 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16931602 0.97 KDM4E (0.50) BBOX1KDM4ETP53CHRNA7LMNA
SCHEMBL302222 0.97
Water SCHEMBL15364815 0.94 KDM4E (0.46) BBOX1KDM4ETP53CHRNA7LMNA
Fluoride Ion SCHEMBL28282209 0.94 KDM4E (0.46) BBOX1KDM4ETP53CHRNA7LMNA
Iodide SCHEMBL3925510 0.94 KDM4E (0.52) BBOX1KDM4ETP53CHRNA7LMNA
SCHEMBL222638 0.94 KDM4E (0.52) BBOX1KDM4ETP53CHRNA7LMNA
Bromide SCHEMBL2191358 0.94 KDM4E (0.46) BBOX1KDM4ETP53CHRNA7LMNA
Fluoride SCHEMBL19181830 0.94 KDM4E (0.46) BBOX1KDM4ETP53CHRNA7LMNA
Ammonia Solution, Strong SCHEMBL17998010 0.94 KDM4E (0.46) BBOX1KDM4ETP53CHRNA7LMNA
Bromide SCHEMBL1976599 0.92 KDM4E (0.50) BBOX1KDM4ETP53CHRNA7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12476287-B2 Dual electrolyte approach for high voltage batteries URBAN ELECTRIC POWER INC. (US) 2025-11-18 US claimed
US-20250313967-A1 Methods for Producing Silicon-Containing Structures Using Redox Mediators and Chemical Reduction CLYRA INC. 2025-10-09 US claimed
US-20240044036-A1 METHODS OF FORMING ACTIVE MATERIALS FOR ELECTROCHEMICAL CELLS USING LOW-TEMPERATURE ELECTROCHEMICAL DEPOSITION GRU Energy Lab Inc. (US) 2024-02-08 US claimed
US-20240047728-A1 ELECTRODE-LESS, MEMBRANE-LESS HIGH VOLTAGE BATTERIES URBAN ELECTRIC POWER INC. 2024-02-08 US claimed
US-20220384855-A1 DUAL ELECTROLYTE APPROACH FOR HIGH VOLTAGE BATTERIES URBAN ELECTRIC POWER INC. 2022-12-01 US claimed
WO-2022140603-A1 ELECTRODE-LESS, MEMBRANE-LESS HIGH VOLTAGE BATTERIES URBAN ELECTRIC POWER INC. (US) 2022-06-30 WO claimed
WO-2021081394-A1 DUAL ELECTROLYTE APPROACH FOR HIGH VOLTAGE BATTERIES URBAN ELECTRIC POWER INC. (US) 2021-04-29 WO claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
US-12476287-B2 Dual electrolyte approach for high voltage batteries URBAN ELECTRIC POWER INC. (US) 2025-11-18 US disclosed
US-20250313967-A1 Methods for Producing Silicon-Containing Structures Using Redox Mediators and Chemical Reduction CLYRA INC. 2025-10-09 US disclosed
US-20250266533-A1 METAL AIR SCAVENGER - AN ENERGY HARVESTING TECHNOLOGY FOR POWERING ELECTRONICS AND ROBOTICS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY 2025-08-21 US disclosed
US-12355061-B2 High voltage batteries using gelled electrolyte RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2025-07-08 US disclosed
WO-2025128460-A1 ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF WILLIAMS RICHARD KENT (US) 2025-06-19 WO disclosed
US-8916039-B2 Aluminum or aluminum alloy barrel electroplating method DIPSOL CHEMICALS CO., LTD. (JP) 2014-12-23 US disclosed
US-20140295238-A1 CURRENT COLLECTOR FOR BATTERY AND SECONDARY BATTERY COMPRISING THE SAME SK INNOVATION CO., LTD. (KR) 2014-10-02 US disclosed
EP-2662478-A1 ELECTRICAL ALUMINIUM OR ALUMINIUM ALLOY FUSED SALT PLATING BATH HAVING GOOD THROWING POWER, AND ELECTROPLATING METHOD AND PRETREATMENT METHOD USING SAME Dipsol Chemicals Co., Ltd. (JP) 2013-11-13 EP disclosed
US-20130292255-A1 ALUMINUM OR ALUMINUM ALLOY MOLTEN SALT ELECTROPLATING BATH HAVING GOOD THROWING POWER, ELECTROPLATING METHOD USING THE BATH, AND PRETREATMENT METHOD OF THE BATH DIPSOL CHEMICALS CO., LTD (JP) 2013-11-07 US disclosed
EP-2492376-A1 METHOD OF BARREL ELECTROPLATING WITH ALUMINUM OR ALUMINUM ALLOY Dipsol Chemicals Co., Ltd. (JP) 2012-08-29 EP disclosed
US-20120205249-A1 Aluminum or Aluminum Alloy Barrel Electroplating Method HONDA MOTOR CO., LTD. (JP) 2012-08-16 US disclosed
US-20120052324-A1 Electric Al-Zr-Mn Alloy-Plating Bath Using Room Temperature Molten Salt Bath, Plating Method Using the Same and Al-Zr-Mn Alloy-Plated Film HONDA MOTOR CO., LTD. (JP) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF CHRM2 433/4885CHRM1 319/4885CHRM3 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.